Akso Health Group ADR Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Consolidated Revenue Annually14.8M
Net Loss Annually
Interim Six-Month Revenue (1H 2026) Quarterly
Watch Items
- Nasdaq Minimum Bid Price ComplianceTrigger: ADS price falling below $1.00 for 30 consecutive business daysAction: Implement strategic measures such as a reverse share split or operational restructuring to maintain listing status.
- Auditor Going Concern WarningTrigger: Auditor flags substantial doubt regarding the company's financial viabilityAction: Secure additional financing, optimize operating costs, or accelerate revenue generation from new healthcare initiatives.
- Brain-Computer Interface (BCI) R&D MilestonesTrigger: Initiation of human clinical trials or regulatory submissions to the FDAAction: Establish foundational R&D infrastructure, file patent applications, and secure strategic clinical partnerships.
Research as of 19 Jun 2026